Extracranial implantable devices, systems and methods for the treatment of medical disorders
First Claim
Patent Images
1. A method for treatment of a medical disorder by trigeminal nerve stimulation, comprising:
- implanting an implantable electrode assembly including a first contact and a second contact above a pericranium and below an epidermis at a patient'"'"'s forehead such that the first contact is in contact with a supraorbital nerve and the second contact is in contact with an adjacent supratrochlear nerve; and
applying electrical signals to the electrode assembly to stimulate the supraorbital nerve and the adjacent supratrochlear nerve at the patient'"'"'s forehead to modulate a body system of the patient to treat the medical disorder selected from the group consisting of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD).
1 Assignment
0 Petitions
Accused Products
Abstract
The present disclosure relates to methods, devices and systems used for the treatment of medical disorders via stimulation of the superficial elements of the trigeminal nerve. More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.
-
Citations
8 Claims
-
1. A method for treatment of a medical disorder by trigeminal nerve stimulation, comprising:
-
implanting an implantable electrode assembly including a first contact and a second contact above a pericranium and below an epidermis at a patient'"'"'s forehead such that the first contact is in contact with a supraorbital nerve and the second contact is in contact with an adjacent supratrochlear nerve; and applying electrical signals to the electrode assembly to stimulate the supraorbital nerve and the adjacent supratrochlear nerve at the patient'"'"'s forehead to modulate a body system of the patient to treat the medical disorder selected from the group consisting of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
Specification